Navidea Biopharmaceuticals Enrolls First Patient in Cervical Cancer Study of Lymphoseek®

Feb 11, 2016

Navidea Biopharmaceuticals to Present at 2016 BIO CEO & Investor Conference

Feb 4, 2016

Navidea Provides Update on Lymphoseek® and Immunodiagnostics Development Pipeline

Feb 2, 2016

Navidea Meets Guidance With 2015 Unaudited Lymphoseek® Sales of $10.2 Million

Jan 11, 2016

Navidea Appoints Anton Gueth Chairman of the Board

Jan 11, 2016

Navidea Biopharmaceuticals Enrolls First Patient in Pediatric Trial of Lymphoseek®

Jan 6, 2016

Navidea Biopharmaceuticals to Present at Biotech Showcase 2016

Jan 4, 2016

Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy

Dec 10, 2015

Lymphoseek® Reduces Sentinel Lymph Node Biopsy Imaging Time, Facilitating Patient Throughput and Workflow Efficiencies

Dec 3, 2015

Navidea Biopharmaceuticals to Present at Stifel 2015 Healthcare Conference

Nov 10, 2015